Discovery of nuclear speckles may improve cancer treatment decisions

FHS
January 2, 2025
11:07 am

Fighting cancer can seem like a deadly game of chance. While some patients may respond well to certain treatments, others might not be as fortunate. Doctors and scientists have long struggled to explain why.

House committee probes FTC disclosure of confidential info in reviewing Amgen-Horizon deal

House Oversight Committee Chair James Comer (R-KY) sent a stern letter to FTC chair Lina Khan last week, claiming the commission improperly disclosed confidential information

November 28, 2023

MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC

Adding a mutation-specific targeted drug to osimertinib (Tagrisso) substantially increased the objective response rate (ORR) in newly diagnosed EGFR-mutant, MET-aberrant non-small cell lung cancer (NSCLC),

September 11, 2024

IQ After Pediatric Concussion; Hearing Aids and Dementia Progression

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange,

July 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.